Jay Sachetti joined Jeff O’Brien, partner at Husch Blackwell and Dyanne Ross-Hanson, president of Exit Planning Strategies talked about the market for mergers and acquisitions, exit planning opportunities for companies that don’t end up for sale and how companies can maximize their eventual sale price during an early October panel at the first Upsize on Tap event at Summit Brewing Co. in St. Paul.
When the state Legislature passed a law requiring employers to provide paid leave and safe time for employees, Justin Bieganek started hearing differing details from friends, colleagues and peers.
AbbeyMoor Medical Inc., the urology company in Parkers Prairie, has a name that has nothing to do with prostetic stents.
John Reid, AbbeyMoor’s chairman, was searching for a name for his new company that would reflect his Scottish background.
One Sunday afternoon, he was looking over a map of Scotland when his wife appeared with a brochure of urological exhibitors for an upcoming trade show.
She pointed out that Abbott Labs, the $19-billion pharmaceutical company, was first in the alphabetically organized list. Pick a name, she said, that will get you in front of Abbott. Reid found AbbeyMoor on the map and decided it was a perfect name.
Has the tactic worked?
“Alphabetically, it has served us well,” says Reid about his company, which has revenue of about $100,000. “It has made a difference.”
John Reid, AbbeyMoor Medical: 218.943.5116; cu*************@**************al.com; www.abbeymoormedical.com
